So there is not--while there is a shortage, it is not as though 75 percent of the people who want or who are normally expected to get vaccinated won't be able to.

The flu vaccine shortage our country is facing has been a wake-up call for all of us.

The flu vaccine shortage our country is facing has been a wake-up call for all of us.

So there is not--while there is a shortage, it is not as though 75 percent of the people who want or who are normally expected to get vaccinated won't be able to.

Clearly, Congress must take action to increase and strengthen the nation's supply of flu vaccine.

I want to commend you for holding this hearing to examine the current flu vaccine shortage

I joined Senator Jack Reed in sending a letter to Secretary Tommy Thompson urging that he do all that he can administratively to optimize the utilization of the existing vaccine.

I joined Senator Jack Reed in sending a letter to Secretary Tommy Thompson urging that he do all that he can administratively to optimize the utilization of the existing vaccine

Clearly, Congress must take action to increase and strengthen the nation's supply of flu vaccine.

I want to commend you for holding this hearing to examine the current flu vaccine shortage.

Mr. Chairman, you have been very generous. If I could submit some additional questions in writing on this, it would be very helpful.

How long, gentlemen, will it take for these Governors and cities to get the approval to bring the vaccines into the United States that they want?

It seems to me getting good flu vaccine out to the American people is Public Health 101.

I think what concerns me is that if we use that model, if somebody comes to the Congress and says, 'Well, there is going to be a problem, we need some money, and we ought to look at incentivization, as sure as the night follows the day, we…

Would FDA like to be the lead agency?

When you see a problem, you essentially bring the relevant people and agencies and you put together the program.

the fact that the two of you would be willing to have your agencies look at heading this up is constructive.

I am just puzzled on one point. Has the agency contacted Glaxo specifically on this matter of documentation, Dr. Crawford?